Why BGPT?
logo

Paper Review — verify claims with raw data

Extract figures, tables, methods, and underlying data to audit results.

Press Enter ↵ to review



    Explore by Goal




     Quick Explanation


    Paper (audit trail): This study tests whether donor diet–driven microbiota (vs donor obesity status) causally influences AOM-induced colorectal cancer (CRC) in recipient mice via antibiotic depletion + fecal microbiota transplant (FMT), finding diet-linked microbiota produce different CRC phenotypes: HFD-microbiota trends toward higher tumor incidence, while WD-microbiota trends toward higher tumor burden and inflammation-related signaling (e.g., SIRPα).
    Key design: Six donor groups (lean/obese × LFD/HFD/WD) → recipient FVB/N mice (antibiotics + repeated FMT) → 5× AOM injections → histology + 16S (V4) + NanoString PanCancer IO 360.



     Long Explanation


    Paper Review (skeptical, evidence-grounded): Diet × Gut Microbiota in the Obesity–CRC Link

    Target paper DOI: 10.1080/01635581.2025.2476779

    1) Visual model of what the authors tested

    The study uses donor mice (lean vs obese; fed LFD vs HFD vs WD) to generate distinct microbiotas, then tests those microbiotas in recipient mice undergoing antibiotic depletion and repeated FMT, followed by AOM-induced CRC.
    Donor & recipient mapping (from methods)
    Factor Levels Where it appears
    Donor obesity status lean (C57BL/6J) vs obese (ob/ob) Donor phenotype labels in each diet group
    Donor diet LFD vs HFD vs WD Defines donor microbiota entering FMT
    Recipient baseline microbiota depleted by antibiotics Recipient pretreatment before first FMT
    CRC induction AOM (5 weekly injections) applied after FMT and during engraftment strategy

    2) Outcome signatures the authors report (visuals)

    2A. Tumor burden (median mm²) where WD-FMT > HFD-FMT numerically
    Note: the paper reports these are numerical medians with no stated statistical significance for the WD-vs-HFD comparison in the burden summary.
    2B. Taxa enriched at the “before tumor development” sampling point (LEfSe, by donor diet)
    The authors report LEfSe-enriched taxa for recipient microbiota prior to tumor development, including: LFD-FMT (S24-7, Lactobacillus, Lactobacillaceae, Clostridiaceae), HFD-FMT (Lachnospiraceae, Dorea, Sutterella), WD-FMT (Bacteroides).
    This figure uses only the count of taxa names listed; it does not represent relative abundance because the full quantitative effect sizes are not provided in the excerpt.

    3) Mechanism claims: what is measured vs what is inferred

    Measured correlates (directly assayed in the study)
    • Donor barrier marker: ZO-1 staining is reported as lower in HFD-fed donor mice compared to LFD-fed donors; MUC2 showed no significant differences in donor mice by diet/obesity status.
    • Recipient tissue inflammation histology: ordered/thresholded histology scores show donor diet effects on inflammation extent/severity/crypt defects and related outcomes, with separation handled using binarization + Firth’s bias-reduced logistic regression.
    • Recipient gene expression marker: NanoString identifies higher SIRPα expression in WD-FMT recipients vs LFD-FMT recipients, with no significant differentially expressed genes reported for the other pairwise diet comparisons as described.
    Inference risks and epistemic limits (critical)
    • Microbiota causality is modeled, but not at single-taxon resolution. FMT shows that community differs by diet and predicts CRC outcomes, but the paper does not directly prove that any one named taxon (e.g., Dorea/Sutterella/Bacteroides) is sufficient/necessary—those statements remain consistent with correlation + enrichment.
    • Statistical power is explicitly reduced for tumor number/burden analyses. The authors note that analyses conditioned on nonzero tumor values reduce effective n (e.g., n=11–16 vs n=18–20 for incidence), which can inflate uncertainty around differences involving tumor number/burden.
    • 16S resolution and database dependence. Taxa are inferred from 16S V4 amplicons and classified using a Greengenes reference classifier; this affects granularity (genus/species ambiguity) and can shift which taxa appear “enriched.”
    • Histological “separation” handling can alter interpretability. The paper reports separation in inflammation extent/severity/crypt defects and uses binarization + Firth correction; that improves model stability but also compresses information into fewer categories.

    4) Methodological audit (high-signal items)

    Microbiome workflow
    • DNA extraction from feces uses bead beating and standard chemical extraction; 16S targets V4 with dual 8-bp barcodes and Illumina MiSeq 2×250 bp.
    • Bioinformatics uses QIIME2 + DADA2 for ASVs; sparse ASVs filtered (<10%); alpha diversity (Shannon; Faith’s PD) and beta diversity (unweighted/weighted UniFrac) analyzed with PERMANOVA and BH FDR (q-values).
    CRC and tissue assessment
    • CRC induced by 5 weekly AOM intraperitoneal injections (10 mg/kg BW/week) after FMT/engraftment timeline.
    • Histological scoring includes inflammatory infiltrate, crypt distortion/defects, epithelial necrosis and tumor grade, assessed by a blinded veterinary pathologist; statistical modeling includes ordinal logistic regression and Firth logistic regression when separation occurs.

    5) Reproducibility and data availability

    The paper states microbiome data are openly available in SRA under BioProject PRJNA1162808.
    That is a major reproducibility strength for the microbiome component. For complete reproducibility, one would still need access to the exact analysis scripts/parameters beyond what is stated in the methods excerpt.

    6) What would most disprove this paper’s core claim?

    • If recipient CRC outcomes do not differ in a reproducible way across donor diet groups when using similar antibiotic + FMT + AOM workflows (despite engraftment verification).
    • If engraftment fails to establish stable donor-diet–specific communities or if diversity/taxa differences do not align with histological/gene-expression readouts.
    • If SIRPα differences (and corresponding histological inflammation phenotypes) disappear in independent replication with pre-specified primary endpoints and without separation-driven binarization altering conclusions.
    Bespoke BGPT follow-ups (action buttons)


    Feedback:    

    Updated: April 08, 2026

     BGPT Paper Review


    Study Novelty

    80%

    The novelty is the explicit comparison of donor obesity status vs donor diet composition using an FMT + antibiotic depletion CRC model, with reported diet-specific differences in tumor incidence vs tumor growth/burden phenotypes and a measured immune-associated gene (SIRPα) in recipient tissues.


    Scientific Quality

    80%

    Scientific quality is high for a mechanistic preclinical microbiome study: clear factorial design (lean/obese × LFD/HFD/WD), engraftment verification described, appropriate microbiome diversity stats (UniFrac, PERMANOVA with BH), and separation handling via Firth/binarization acknowledged. Main quality caveats are reduced power for conditioned tumor-number/burden analyses, limited taxonomic resolution inherent to 16S V4 + reference classification, and no direct single-taxon sufficiency/necessity tests.


    Study Generality

    70%

    The mechanisms are plausibly diet-composition dependent and microbiota-mediated, but the evidence is generated in a specific mouse model (male donors/recipients, strains, antibiotic regimen, AOM dosing, 16S V4). That limits translation/generalization across human diets, sexes, microbiome measurement platforms, and CRC etiologies.


    Study Usefulness

    80%

    Usefulness is high because it provides a tractable experimental framework for distinguishing diet-composition effects on microbiota-driven CRC initiation vs progression and supplies open microbiome data (SRA PRJNA1162808) that can be reanalyzed.


    Study Reproducibility

    80%

    Reproducibility is supported by detailed methods and open SRA data; however, full computational reproducibility may still depend on availability of exact scripts/versions and on how taxa were filtered/annotated in all steps. The excerpt includes enough methodological detail to reimplement the analysis pipeline in principle.


    Explanatory Depth

    70%

    The paper provides mechanistic correlates (ZO-1 barrier marker in donors; inflammation histology and SIRPα expression in recipients) and a plausible narrative for diet-dependent microbiota shaping CRC phenotypes. But mechanistic depth is limited by whole-community transfer design and lack of targeted causality experiments (e.g., metabolite quantification, single-taxon intervention).


    🎁 Authors: Collect 401 Free Science Tokens (≈ $40.1 USD)

    Claim My Author Tokens

    Use for 100 days of free BGPT access (4 tokens = 1 day) or trade/sell (≈ $40.1 USD)

     Top Data Sources ExportMCP


     Analysis Wizard



    It will download SRA reads for PRJNA1162808, rerun QC/16S denoising to ASVs, then re-fit diversity + LEfSe models to reproduce taxa→histology associations using the paper’s endpoints.



     Hypothesis Graveyard


    The simplest “obesity alone causes microbiota-mediated CRC” hypothesis is weakened here because donor obesity status (lean vs obese at fixed diet) is reported as less predictive than donor diet.


    The “one enriched genus explains everything” strongman hypothesis is unlikely because the study’s causal lever is whole microbiota FMT and the paper reports only limited gene-expression differences (not broad immune cell type shifts) while histology shows multiple affected categories.

     Science Art


    Paper Review: The Role of Diet and the Gut Microbiota in the Obesity-Colorectal Cancer Link Science Art

     Science Movie


    Make a narrated HD Science movie for this answer ($32 per minute)




     Discussion


    Follow the Evidence

    New scientific claims, supporting evidence, and important limitations. Every Friday. No ads.


    My BGPT






     Trending